Technical Analysis for PRFX - PainReform Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.84 | 0.00% | 0.00 |
PRFX closed unchanged on Monday, March 18, 2024, on 29 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -2.65% | |
Stochastic Reached Oversold | Weakness | -2.65% | |
Down 3 Days in a Row | Weakness | -2.65% |
Alert | Time |
---|---|
Up 3% | about 16 hours ago |
Possible NR7 | about 18 hours ago |
Possible Inside Day | about 18 hours ago |
60 Minute Opening Range Breakout | about 19 hours ago |
Up 2% | about 19 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/12/2024
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Opioids Pharmaceutical Sciences Hepatotoxins Nonsteroidal Anti Inflammatory Drug
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 26.41 |
52 Week Low | 1.8216 |
Average Volume | 16,114 |
200-Day Moving Average | 3.66 |
50-Day Moving Average | 2.11 |
20-Day Moving Average | 1.99 |
10-Day Moving Average | 1.98 |
Average True Range | 0.16 |
RSI (14) | 40.12 |
ADX | 16.23 |
+DI | 18.03 |
-DI | 16.32 |
Chandelier Exit (Long, 3 ATRs) | 1.96 |
Chandelier Exit (Short, 3 ATRs) | 2.30 |
Upper Bollinger Bands | 2.21 |
Lower Bollinger Band | 1.76 |
Percent B (%b) | 0.17 |
BandWidth | 22.68 |
MACD Line | -0.06 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0133 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.92 | ||||
Resistance 3 (R3) | 1.93 | 1.91 | 1.91 | ||
Resistance 2 (R2) | 1.91 | 1.89 | 1.91 | 1.91 | |
Resistance 1 (R1) | 1.88 | 1.88 | 1.87 | 1.87 | 1.90 |
Pivot Point | 1.86 | 1.86 | 1.85 | 1.85 | 1.86 |
Support 1 (S1) | 1.82 | 1.84 | 1.81 | 1.81 | 1.78 |
Support 2 (S2) | 1.80 | 1.82 | 1.80 | 1.77 | |
Support 3 (S3) | 1.77 | 1.80 | 1.77 | ||
Support 4 (S4) | 1.76 |